Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ABL1 |
Variant | Y253H |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | ABL1 Y253H lies within the protein kinase domain of the Abl1 protein (UniProt.org). Y253H has been associated with resistance to Abl1 inhibitors (PMID: 29375916, PMID: 16482207), and demonstrates a modest increase in catalytic efficiency (kcat/km) in an in vitro assay (PMID: 30684523), but does not result in increased kinase activity or growth advantage in the context of BCR-ABL1 compared to wild-type BCR-ABL1 (PMID: 16482207), and therefore, its effect on Abl1 protein function is unknown. |
Associated Drug Resistance | Y |
Category Variants Paths |
ABL1 mutant ABL1 Y253H |
Transcript | NM_005157.6 |
gDNA | chr9:g.130862970T>C |
cDNA | c.757T>C |
Protein | p.Y253H |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_005157.6 | chr9:g.130862970T>C | c.757T>C | p.Y253H | RefSeq | GRCh38/hg38 |
NM_005157.5 | chr9:g.130862970T>C | c.757T>C | p.Y253H | RefSeq | GRCh38/hg38 |
NM_005157 | chr9:g.130862970T>C | c.757T>C | p.Y253H | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|